Please login to the form below

Not currently logged in
Email:
Password:

Pfizer/BioNTech

This page shows the latest Pfizer/BioNTech news and features for those working in and with pharma, biotech and healthcare.

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval

The potential approval of CVnCoV comes months after the emergency authorisations of other mRNA-based vaccines, namely Moderna and Pfizer/BioNTech’s respective jabs.

Latest news

More from news
Approximately 46 fully matching, plus 98 partially matching documents found.

Latest Intelligence

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University

  • Working together against COVID-19 Working together against COVID-19

    Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same. ... A number of top pharma companies are included in the newly

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • What does the COVID-19 vaccine mean for the future of R&D? What does the COVID-19 vaccine mean for the future of R&D?

    Both the Oxford/AstraZeneca and Pfizer/BioNTech vaccines were developed using platform technologies which didn’t exist 20 years ago, allowing these vaccines to be developed much faster.

  • The UK has approved the first vaccine for COVID-19. What now? The UK has approved the first vaccine for COVID-19. What now?

    The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so

  • Mistrust in medical research: a patient perspective

    Health Products Regulatory Agency’s speedy  approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the

  • Is the world ready for a COVID-19 vaccine? Is the world ready for a COVID-19 vaccine?

    At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection. ... At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more

  • Hanover Communications Hanover Communications

    At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics